Ritchie, C W <br/><br/>
The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.  [electronic resource] 

 -  International journal of geriatric psychiatry  May 2003 
 - 432-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0885-6230 
<br/><br/><label>Standard No.: </label>10.1002/gps.862  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antipsychotic Agents--adverse effects<br/>Benzodiazepines<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Olanzapine<br/>Pirenzepine--adverse effects<br/>Psychomotor Disorders--chemically induced<br/>Quality of Life<br/>Risperidone--adverse effects<br/>Schizophrenia--drug therapy